This poster explores how small molecule microarrays (SMM) simplifies the drug discovery workflow ... and make quick decisions about weak binders. with the Breaking Science News daily newsletter ...

Global Life Science Leader Leverages Online Research Platform to Streamline Access to Its Cutting-Edge Drug Discovery and Development Solutions SAN DIEGO, September 09, 2024--(BUSINESS WIRE ...

A former scientist at Google's DeepMind who co-developed the AlphaFold2 protein prediction platform, Dr Simon Kohl, has launched his own venture applying artificial intelligence to drug discovery.

The company recently developed a novel, recombinant protein-based chip for identifying protein binding "signatures" in vitro. 1 Candidate pharmaceutical compounds are passed over a prefabricated chip ...

Join us for a science symposium where cutting-edge biology meets ... In-person attendees are also invited to present recent posters on biomarker discovery and multiomics. Transportation from the Santa ...

A US clinical-stage biotechnology company has introduced the first bipedal humanoid robot in its AI-driven, fully automated ...

such high-profile failures show that the drug development process is far from flawless. The good news is that the number of targets has increased, as has the supply and demand for high-throughput ...

Thus, there is a need for a better model to predict these events in drug discovery. DILI can occur ... Dr. Emily Richardson is a Lead Scientist in the R&D team at CN Bio. Joining the team in ...

The humanoid, called “Supervisor” will be used for data acquisition and data generation for training of the embodied AI systems to learn the skills of human laboratory scientists. The work ...